Eurocine Vaccines is publically listed at Spotlight Stock Market XSAT, Sweden, with the ticker EUCI.
To be notified with news, sign up to our newsfeed =>
Sedermera is our Financial Advisor.
Preferential Share Issue
Eurocine Vaccines AB publishes an Information Memorandum in connection with the Company´s preferential issue of shares up to cirka 9,7 MSEK before issue costs, which subscription period begins Wednesday 2 August 2023.
Eurocine Vaccines´ Memorandum 2023 (in Swedish)
Supplementary Memorandum 7 August 2023 (Tilläggsmemorandum, in Swedish)
Extraordinary General Meeting
26 July 2023
Below follow documents related to the Extraordinary General Meeting on the 26 July 2023:
Latest Investor Presentation
Future Financial Reports
The Interim Report July – September 2023 is planned to be available 28 November 2023.